Trials / Completed
CompletedNCT01293331
Study of Febrile Illness for Dengue-Endemic Areas in Latin America
Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Latin America
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 9 Years – 16 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to detect acute febrile episodes and dengue infection in five Latin American countries to assess dengue seroprevalence. Primary objectives: * To identify acute febrile episodes among the cohort in order to detect the presence of dengue infection. * To describe the dengue seroprevalence among the cohort at baseline and at the end of the study.
Detailed description
All participants will make two visits to a study site, an enrollment visit and a termination visit. Additional visits will be made if febrile episodes occur: an acute visit and a convalescent visit. Participants or their parents/guardians will be contacted weekly to monitor the occurrence of febrile episodes and ensure appropriate assessment and care. No vaccine will be provided or administered in this study
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-12-01
- Completion
- 2012-04-01
- First posted
- 2011-02-10
- Last updated
- 2015-06-17
Locations
18 sites across 4 countries: Brazil, Colombia, Mexico, Puerto Rico
Source: ClinicalTrials.gov record NCT01293331. Inclusion in this directory is not an endorsement.